Surveillance for influenza during the 2009 influenza A (H1N1) pandemic-United States, April 2009-March 2010
Brammer L, Blanton, L, Epperson S, et al. Surveillance for influenza during the 2009 influenza A (H1N1) pandemic-United States, April 2009-March 2010. Clin Infect Dis 2011;52 (Suppl 1):S27-35.
World Health Organization, September 2010-March 2011, Geneva, Switzerland: World Health Organization; 2011. Available at, Accessed October 1,
World Health Organization. Summary of influenza antiviral susceptibility surveillance findings, September 2010-March 2011. Geneva, Switzerland: World Health Organization; 2011. Available at http://www.who.int/csr/ disease/influenza/influenzanetwork/flunet/antiviral_susceptibility/en/ index.html. Accessed October 1, 2012.
Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccination on cross-reactive antibodies-United States
CDC
CDC. Antibodies cross-reactive to influenza A (H3N2) variant virus and impact of 2010-11 seasonal influenza vaccination on cross-reactive antibodies-United States. MMWR 2012;61:237-41.
CDC, Atlanta, GA: US Department of Health and Human Services, CDC; 2012. Available at, Accessed October 1,
CDC. Interim guidance for enhanced influenza surveillance: additional specimen collection for detection of influenza A (H3N2) variant virus infection. Atlanta, GA: US Department of Health and Human Services, CDC; 2012. Available at http://www.cdc.gov/flu/swineflu/h3n2vsurveillance.htm. Accessed October 1, 2012.
Prevention and control of influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2012-13 influenza season
CDC
CDC. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)-United States, 2012-13 influenza season. MMWR 2012;61:613-8.
Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP)
CDC, (No. RR-1)
CDC. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011;60(No. RR-1).